units

ECX9710

Faculty of Business and Economics

Postgraduate - Unit

This unit entry is for students who completed this unit in 2013 only. For students planning to study the unit, please refer to the unit indexes in the the current edition of the Handbook. If you have any queries contact the managing faculty for your course or area of study.

print version

6 points, SCA Band 3, 0.125 EFTSL

To find units available for enrolment in the current year, you must make sure you use the indexes and browse unit tool in the current edition of the Handbook.

LevelPostgraduate
FacultyFaculty of Business and Economics
Organisational UnitDepartment of Economics
OfferedClayton Second semester 2013 (Off-campus)
Coordinator(s)Associate Professor Duncan Mortimer

Synopsis

The economics of the pharmaceutical industry including the market for pharmaceuticals and its regulation internationally and in Australia. Principles of economic evaluation of the costs and outcomes of pharmaceutical products, and provides a guide to best practice with particular emphasis on clinical trials and protocol design.

Outcomes

The learning goals associated with this unit are to:

  1. economic analysis in the pharmaceutical industry
  2. structure of the pharmaceutical industry and the inter-relationship between the nature of the product, market structure and government regulation
  3. impact of government intervention in the pharmaceutical industry including alternative regulatory regimes
  4. role of economic evaluation in promoting the efficient use of drugs
  5. economic analysis of drugs alongside clinical trials, including techniques of health outcome measurement.

Assessment

Within semester assessment: 70%
Examination: 30%

Chief examiner(s)